Cost-Utility Analysis of Dolutegravir/Abacavir/Lamivudine (Dtg/Abc/3tc) as a Single Tablet Treatment of Naïve Hiv Infected Patientss
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.1507
https://www.valueinhealthjournal.com/article/S1098-3015(15)03583-4/fulltext
Title :
Cost-Utility Analysis of Dolutegravir/Abacavir/Lamivudine (Dtg/Abc/3tc) as a Single Tablet Treatment of Naïve Hiv Infected Patientss
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)03583-4&doi=10.1016/j.jval.2015.09.1507
First page :
A588
Section Title :
Research Podium Presentations - Session 1 and Session 2
Open access? :
No
Section Order :
1408